Skip to navigation Skip to content

Participe en una prueba clínica

Sin la participación de personas con esclerosis múltiple, sería imposible desarrollar nuevos y mejores tratamientos, y otras intervenciones.

Share

Nos esforzamos por traducir cada vez más contenido al español, pero algunos de los enlaces incluidos aquí van a páginas en inglés. Si usa el traductor de su navegador, tenga en cuenta que es posible que la traducción no sea exacta.

Pruebas clínicas cercanas

¿Tiene interés en las pruebas clínicas? Simplemente busque por estado, tipo de esclerosis múltiple o palabra clave, y vea qué está sucediendo en su zona.

v
  1. Clinical trial: MS self-management app

    Many people with MS have been looking for a self-management app tailored to their needs in managing MS and health needs on their MS journey. Researchers at the University of Illinois worked with MS patients and clinicians to develop a new self-management app, SavvyHealth. We n...
  2. Clinical Trial: Multiple Sclerosis Online Course

    Course duration: 24 July to 3 Sep 2023 Estimate effort: 1-2 hr per week Cost fee: Free Content: Introduction to MS, diet, vitamin D, exercise, mindfulness, medication, pregnancy, family & prevention Eligibility: Adults with diagnosed MS The MS Online Course study ...
  3. Clinical Trial: Ocrelizumab for Preventing MS in Individuals With Radiologically Isolated Disease

    “Radiologically isolated syndrome” (RIS) is diagnosed when it is discovered that someone has brain MRI abnormalities similar in appearance and location to abnormalities seen in people with MS. People with RIS are typically otherwise healthy and without any symptoms common for ...
  4. Clinical Trial: Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

    This study will evaluate the effectiveness and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including participants later in their disease course. This study focuses on upper limit disability progres...
  5. Clinical Trial: Ocrelizumab vs. fingolimod in children and adolescents with MS

    Study is seeking to assess the safety and effectiveness of ocrelizumab (administered by intravenous infusion every 24 weeks) in comparison to fingolimod (one oral capsule taken once per day) in children and adolescents ages 10 to 18 with relapsing-remitting MS. The study is co...
  6. Clinical Trial: Online Program to Increase Physical Activity in Persons Newly Diagnosed with MS

    Researchers at the University of Alabama at Birmingham are conducting an online behavior change intervention to promote lifestyle physical activity among persons diagnosed with MS within the last 2 years . The researchers aim to examine the effects of the program in helping...
  7. Clinical Trial: Pathological Basis of MRI Signal Changes in Multiple Sclerosis

    Multiple sclerosis (MS) is a disease that damages the central nervous system (brain and spinal cord). This leads to increased physical disability over time. The disease is lifelong once it begins. Researchers want to learn more about the stages of multiple sclerosis and follow...
  8. Clinical Trial: Physical therapy for balance

    We would like to investigate the use of motor imagery and physical practice on balance in persons with MS through the use of a home exercise program - this means practicing your balance training at home and NOT in a clinic.  Motor Imagery is imagining oneself performing a task...
  9. Clinical Trial: Probiotic for Urinary Symptoms Among People Who Use Catheters (Remote)

    To qualify for this study you must be 18 years or older, use an indwelling catheter OR Intermittent catheter, be diagnosed with MS, and have a history of 2 or more episodes of urinary symptoms or infection in the past year. Researchers at MedStar National Rehabilitation Hos...
  10. Clinical Trial: Protective Step Training in People With MS

    Falls are common in people with multiple sclerosis (MS), and current rehabilitation approaches to reduce falls are inadequate. A novel and promising rehabilitation training program: Protective step training (in which a person is exposed to repeated "slips") has been developed ...
  11.  |<  <  2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11  >  >| 

Share


© 2024 La Sociedad Nacional de Esclerosis Múltiple es una entidad sin fines de lucro de tipo 501(c)3 y exenta de impuestos. Su número de identificación (EIN por su sigla en inglés) es 13-5661935.